However, CAY10683 and BG45, two known HDAC2 inhibitors, reduced the frequency of AF+ cells, corroborating the role of an HDAC2-dependent epigenetic program in promoting AF+ cells (Figure 6A–B). This evidence concerns the gene HDAC2 and atrial fibrillation.